Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Comparative Study to Assess the Efficacy and Safety of Oral Rehydration Therapy (ORT) in Combination With Spores of Bacillus Clausii (Enterogermina)Versus ORT Alone, Administered for 5 Days With the Treatment of Acute Diarrhea in Children.

NCT00457353 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00457353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00457353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Comparative Study to Assess the Efficacy and Safety of Oral Rehydration Therapy (ORT) in Combination With Spores of Bacillus Clausii (Enterogermina)Versus ORT Alone, Administered for 5 Days With the Treatment of Acute Diarrhea in Children.
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
Not reported
Enrollment
264 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroenteritis